In vivo Raman spectroscopy of breast tumors prephotodynamic and postphotodynamic therapy

[1]  P. Bult,et al.  Screen-detected breast cancers have a lower mitotic activity index , 2000, British Journal of Cancer.

[2]  Yan Li,et al.  Collagen as a double-edged sword in tumor progression , 2013, Tumor Biology.

[3]  L. Neumayer,et al.  Breast cancer: a review for the general surgeon. , 2013, JAMA surgery.

[4]  P. V. van Diest,et al.  Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis , 1998, The Journal of pathology.

[5]  C. Krishna,et al.  Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy. , 2006, Biopolymers.

[6]  L. Pusztai,et al.  Multigene prognostic tests in breast cancer: past, present, future , 2015, Breast Cancer Research.

[7]  P. V. van Diest,et al.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. , 1997, The American journal of pathology.

[8]  M. Morris,et al.  Raman spectroscopy demonstrates prolonged alteration of bone chemical composition following extremity localized irradiation. , 2013, Bone.

[9]  Weiqing Xu,et al.  The Clinical Application of Raman Spectroscopy for Breast Cancer Detection , 2017 .

[10]  C Murali Krishna,et al.  Prediction of radiotherapy response in cervix cancer by Raman spectroscopy: A pilot study , 2008, Biopolymers.

[11]  C. Krishna,et al.  Transcutaneous in vivo Raman spectroscopy: Detection of age-related changes in mouse breast , 2013 .

[12]  A. Talari,et al.  Raman Spectroscopy of Biological Tissues , 2007 .

[13]  R. Skjaerven,et al.  Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. , 1996, Journal of clinical pathology.

[14]  R. Dasari,et al.  Prospects for in vivo Raman spectroscopy , 2000 .

[15]  J. Baak,et al.  Prognostic value of proliferation in invasive breast cancer: a review , 2004, Journal of Clinical Pathology.

[16]  W. Dietel,et al.  Phototransformation of Sensitisers: 3. Implications for Clinical Dosimetry , 1998, Lasers in Medical Science.

[17]  Giedre Streckyte,et al.  Phototransformations of sensitizers 2. Photoproducts formed in aqueous solutions of porphyrins , 1997 .

[18]  Halina Abramczyk,et al.  Oncologic photodynamic diagnosis and therapy: confocal Raman/fluorescence imaging of metal phthalocyanines in human breast cancer tissue in vitro. , 2014, The Analyst.

[19]  C. Murali Krishna,et al.  Swiss bare mice: a suitable model for transcutaneous in vivo Raman spectroscopic studies of breast cancer , 2013, Lasers in Medical Science.

[20]  V. B. Kartha,et al.  Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: A Raman spectroscopy study , 2006, Biopolymers.

[21]  C. Murali Krishna,et al.  Tissue Raman Spectroscopy for the Study of Radiation Damage: Brain Irradiation of Mice , 2002, Radiation Research.

[22]  Giedre Streckyte,et al.  Phototransformations of sensitizers 1. Significance of the nature of the sensitizer in the photobleaching process and photoproduct formation in aqueous solution , 1997 .

[23]  C. Krishna,et al.  Transcutaneous in vivo Raman spectroscopy of breast tumors and pretumors , 2015 .

[24]  H. Abramczyk,et al.  Raman imaging in biochemical and biomedical applications. Diagnosis and treatment of breast cancer. , 2013, Chemical reviews.

[25]  A. Jirasek,et al.  Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy , 2011, Physics in medicine and biology.

[26]  B. Wilson,et al.  A review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncology , 2016, Physics in medicine and biology.

[27]  B. Angus,et al.  A study of interval breast cancer within the NHS breast screening programme , 2000, Journal of clinical pathology.

[28]  R. Dasari,et al.  Diagnosing breast cancer by using Raman spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Barr,et al.  Advances in the clinical application of Raman spectroscopy for cancer diagnostics. , 2013, Photodiagnosis and photodynamic therapy.

[30]  Andrei V. Reshetnickov,et al.  Novel drug form of chlorin e6 , 2000, BiOS.

[31]  R. Dasari,et al.  Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis in vivo , 2002 .

[32]  I. Ellis,et al.  Recommendations for HER2 testing in the UK , 2000, Journal of clinical pathology.

[33]  Halina Abramczyk,et al.  New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin. , 2016, Analytica chimica acta.

[34]  Marian Cholewa,et al.  Application of Raman Spectroscopy and Infrared Spectroscopy in the Identification of Breast Cancer , 2016, Applied spectroscopy.

[35]  Zhe Chuan Feng,et al.  Raman Spectroscopic Characterization of Human Breast Tissues: Implications for Breast Cancer Diagnosis , 1993 .

[36]  M. Schmitt,et al.  Advantages and limitations of Raman spectroscopy for molecular diagnostics: an update , 2015, Expert review of molecular diagnostics.

[37]  P. V. van Diest,et al.  Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops , 1998, The Journal of pathology.